Capital expenditure increased 27.4%
Capital expenditure changed +27.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$2.5M→$3.2M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →OSPN financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income increased 12.3%
Operating income changed +12.3% from the comparable as-filed period.
$8.2M→$9.2M2 prior comparisons
Revenue increased 12.0%
Revenue changed +12.0% from the comparable as-filed period.
$57.1M→$63.9M2 prior comparisons
Inventory / revenue moved 231 bp lower
Inventory / revenue changed -231 basis points from the comparable as-filed period.
19.69%→17.38%2 prior comparisons
Receivables / revenue moved 1733 bp higher
Receivables / revenue changed +1733 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
48.16%→65.50%2 prior comparisons
SBC / revenue moved 267 bp higher
SBC / revenue changed +267 basis points from the comparable as-filed period.
5.91%→8.58%2 prior comparisons
Stock-based compensation increased 62.5%
Stock-based compensation changed +62.5% from the comparable as-filed period.
$3.4M→$5.5M2 prior comparisons
Free-cash-flow margin moved 540 bp higher
Free-cash-flow margin changed +540 basis points from the comparable as-filed period.
15.37%→20.76%2 prior comparisons
Operating cash-flow margin moved 601 bp higher
Operating cash-flow margin changed +601 basis points from the comparable as-filed period.
19.81%→25.82%2 prior comparisons
Total assets increased 16.2%
Total assets changed +16.2% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$343.5M→$399.2M4 prior comparisons
Gross profit increased 16.0%
Gross profit changed +16.0% from the comparable as-filed period.
$42.0M→$48.7M2 prior comparisons
Operating margin moved 5 bp higher
Operating margin changed +5 basis points from the comparable as-filed period.
14.42%→14.47%2 prior comparisons
Current assets decreased 12.0%
Current assets changed -12.0% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$157.5M→$138.6M4 prior comparisons
Current ratio decreased 23.1%
Current ratio changed -23.1% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
1.75→1.354 prior comparisons
Capex / revenue moved 61 bp higher
Capex / revenue changed +61 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
4.44%→5.05%2 prior comparisons
Research & development increased 12.6%
Research & development changed +12.6% from the comparable as-filed period.
$8.8M→$9.9M2 prior comparisons
Shares outstanding decreased 3.0%
Shares outstanding changed -3.0% from the comparable as-filed period. The change ranks at the 62th percentile of 8 prior comparable changes.
38,027,123→36,894,7898 prior comparisons
Cost of revenue increased 0.6%
Cost of revenue changed +0.6% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$15.1M→$15.2M2 prior comparisons
Inventory decreased 1.2%
Inventory changed -1.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$11.2M→$11.1M4 prior comparisons
R&D / revenue moved 9 bp higher
R&D / revenue changed +9 basis points from the comparable as-filed period.
15.42%→15.51%2 prior comparisons
Capex / revenue moved 215 bp higher
Capex / revenue changed +215 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
3.10%→5.25%2 prior comparisons
Free-cash-flow proxy changed across a sign change
Free-cash-flow proxy changed -175.2% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
$4.4M→-$3.3M3 prior comparisons
Receivables / revenue moved 829 bp higher
Receivables / revenue changed +829 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
58.59%→66.89%2 prior comparisons
Free-cash-flow margin moved 1271 bp lower
Free-cash-flow margin changed -1271 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
7.29%→-5.42%2 prior comparisons
Operating cash flow changed across a sign change
Operating cash flow changed -101.7% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
$6.2M→-$103,0003 prior comparisons
Operating cash-flow margin moved 1056 bp lower
Operating cash-flow margin changed -1056 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
10.39%→-0.17%2 prior comparisons
Capital expenditure increased 71.1%
Capital expenditure changed +71.1% from the comparable as-filed period.
$1.9M→$3.2M3 prior comparisons
Revenue increased 1.0%
Revenue changed +1.0% from the comparable as-filed period.
$59.8M→$60.5M2 prior comparisons
Gross margin moved 10 bp higher
Gross margin changed +10 basis points from the comparable as-filed period.
73.47%→73.57%2 prior comparisons
Inventory decreased 16.9%
Inventory changed -16.9% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$11.4M→$9.5M4 prior comparisons
Total assets increased 8.4%
Total assets changed +8.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$357.1M→$387.0M4 prior comparisons
Research & development increased 4.9%
Research & development changed +4.9% from the comparable as-filed period.
$9.4M→$9.9M2 prior comparisons
Current liabilities increased 0.7%
Current liabilities changed +0.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$95.6M→$96.2M4 prior comparisons
SBC / revenue moved 7 bp lower
SBC / revenue changed -7 basis points from the comparable as-filed period.
5.77%→5.69%2 prior comparisons
Cost of revenue increased 0.7%
Cost of revenue changed +0.7% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$15.9M→$16.0M2 prior comparisons
R&D / revenue moved 60 bp higher
R&D / revenue changed +60 basis points from the comparable as-filed period.
15.78%→16.39%2 prior comparisons
Gross profit increased 1.2%
Gross profit changed +1.2% from the comparable as-filed period.
$44.0M→$44.5M2 prior comparisons
Stock-based compensation decreased 0.3%
Stock-based compensation changed -0.3% from the comparable as-filed period.
$3.5M→$3.4M2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.